Abstract 9092: Association of Biomarkers of Oxidative Stress, Inflammation, and Cardiac Damage with Long-Term Radiation-Induced Cardiovascular Outcomes in Breast Cancer
Alexi VasbinderSusan R HeckbertRichard ChengHilaire J ThompsonOleg ZaslavskyRowan ChlebowskiLisa JohnsonRachel YungJean Wactawski-WendeAladdin H ShadyabGretchen WellsLisa Warsinger Martinelectra paskettKerryn RedingUniv of Washington Sch of Nursing,Seattle,WAUniv of Washington Sch of Public Health,Seattle,WAUniv of Washington Sch of Medicine,Seattle,WALundquist Institute,Torrance,CAPublic Health Sciences Div,Fred Hutchinson Cancer Rsch Cntr,Seattle,WAEpidemiology and Environmental Health,Univ at Buffalo Sch of Public Health and Health Professions,Buffalo,NYUniv of California,San Diego,La Jolla,CAUniv of Kentucky College of Medicine,Lexington,KYGeorge Washington Univ Sch of Medicine and Health Sciences,Washington D.C.,DCDiv of Cancer Prevention and Control,The Ohio State Univ,OH
DOI: https://doi.org/10.1161/circ.144.suppl_1.9092
IF: 37.8
2021-11-10
Circulation
Abstract:Introduction: Radiation therapy (RT) is a common component of breast cancer (BC) management, but may be associated with radiation-induced cardiovascular disease (RICVD) which includes coronary heart disease, myocardial infarction, CVD death, heart failure, or stroke. We examined associations of biomarkers of oxidative stress (MPO, GDF-15, 8-OH-dG, PGF), cardiac injury (TnI, Cystatin-C), inflammation (IL-6, CRP), and myocardial fibrosis (TGF-B) with long-term RICVD in BC survivors. Methods: In an ancillary, nested case-control study within the Women's Health Initiative, postmenopausal women with incident BC stages I-III, who received RT, and had pre- and post-BC diagnosis serum samples available not more than 3 years apart were eligible. Cases were defined as developing incident, physician-adjudicated coronary heart disease, myocardial infarction, CVD death, heart failure, or stroke after BC. Each case was matched to 3 controls on enrollment age and visit year of pre-BC blood draw. Biomarkers were analyzed using enzyme-linked immunosorbent assays and modeled as the post-BC to pre-BC ratio and log transformed to base 2. Logistic regression models were adjusted for demographic, lifestyle, and cancer characteristics. Results: A total of 55 cases and 158 controls were included with a mean (SD) age of 66.9 (5.5) years and a median (IQR) time from BC diagnosis to post-BC serum collection of 1.4 (0.7, 2.4) years. After adjustment, a higher 8-OH-dG ratio was significantly associated with an elevated risk of RICVD (Table). For a doubling in the biomarker ratio, RICVD risk was 3.04-fold higher (95% CI: 1.01, 9.21). Other biomarkers were not associated with RICVD risk. Conclusions: In this study, higher concentrations of 8-OH-dG were associated with a higher risk of RICVD. This suggests that oxidative DNA damage may be a putative pathway for delayed RICVD. However, given the sample size and multiple testing, further studies are needed to confirm or refute these findings.
cardiac & cardiovascular systems,peripheral vascular disease